Increased Lymphocyte Infiltration in NSCLC Neoadjuvant Chemo-Immunotherapy Non-responders: A Biomarker of T-Cell Dysfunction and Prognosis?
Woodard G, Cho C, Chen L. Increased Lymphocyte Infiltration in NSCLC Neoadjuvant Chemo-Immunotherapy Non-responders: A Biomarker of T-Cell Dysfunction and Prognosis? Annals Of Surgical Oncology 2023, 31: 25-27. PMID: 37899411, DOI: 10.1245/s10434-023-14388-1.Peer-Reviewed Original Research